| 1 |
2019 |
Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. II. Antibodies subclasses. |
PRP |
| 2 |
2019 |
Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy-a prospective, observational cohort study from the United Kingdom. |
DTx, FHA, Ig, PRN, PTX, TTx |
| 3 |
2019 |
Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b. |
CPS, PRP |
| 4 |
2019 |
Effect of nontypeable Haemophilus influenzae protein E (PE) as a microbial adjuvant on the amount of antibody against PRP of Haemophilus influenzae type b (Hib) in BALB/c mice. |
PE |
| 5 |
2019 |
Effectiveness of Haemophilus influenzae type b vaccination after splenectomy - impact on selected immunological parameters. |
NK, NKT, Treg |
| 6 |
2019 |
Factors associated with uptake of Haemophilus influenzae type b vaccination in Shanghai, China. |
--- |
| 7 |
2019 |
Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease. |
SCD |
| 8 |
2019 |
Sustained reductions of invasive infectious disease following general infant Hib- and pneumococcal vaccination in a Swedish Arctic region. |
--- |
| 9 |
2019 |
Today's vaccination policies in Italy: The National Plan for Vaccine Prevention 2017-2019 and the Law 119/2017 on the mandatory vaccinations. |
MMR |
| 10 |
2019 |
Vaccination herd effect experience in Latin America: a systematic literature review. |
LATAM, PCV, VHL |
| 11 |
2019 |
[Acute meningitis and encephalitis syndrome surveillance disease burden in four China prefectures]. |
AMES, Nm, SP |
| 12 |
2018 |
A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate. |
PRP |
| 13 |
2018 |
A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan. |
CI, IRR |
| 14 |
2018 |
A post-conflict vaccination campaign, Central African Republic. |
DTP, PCV |
| 15 |
2018 |
A Registry for Patients With Asplenia/Hyposplenism Reduces the Risk of Infections With Encapsulated Organisms. |
IMD, IPD, OPSI |
| 16 |
2018 |
Acute epiglottitis caused by community-acquired methicillin-resistant Staphylococcus aureus in a healthy infant. |
MRSA |
| 17 |
2018 |
Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center. |
HSCT |
| 18 |
2018 |
Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies. |
GMC, PRP |
| 19 |
2018 |
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. |
PCV, UR |
| 20 |
2018 |
Characterization of Vaccination Policies for Attendance and Employment at Day/Summer Camps in New York State. |
DTaP, MMR, Tdap |
| 21 |
2018 |
Clinical and Bacteriologic Analysis of Nontypeable Haemophilus influenzae Strains Isolated from Children with Invasive Diseases in Japan from 2008 to 2015. |
NTHi |
| 22 |
2018 |
Comparison of serum bactericidal and antibody titers induced by two Haemophilus influenzae type b conjugate vaccines: A phase III randomized double-blind study. |
SBA |
| 23 |
2018 |
Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. |
RCTs, SCD |
| 24 |
2018 |
Cord Blood Antiparasite Interleukin 10 as a Risk Marker for Compromised Vaccine Immunogenicity in Early Childhood. |
DT, HBV, IgG, PC |
| 25 |
2018 |
Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China. |
ICER, UNICEF |
| 26 |
2018 |
Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015. |
--- |
| 27 |
2018 |
Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. |
--- |
| 28 |
2018 |
Expanded program of immunization in the Maghreb. Case study of Tunisia.Systematic review of the literature. |
EPI |
| 29 |
2018 |
Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law. |
--- |
| 30 |
2018 |
Global Routine Vaccination Coverage - 2017. |
GVAP, HepB, UNICEF, WHO |
| 31 |
2018 |
Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales. |
anti-PRP |
| 32 |
2018 |
IgE anti-Haemophilus influenzae type b (Hib) antibodies detected in serum of Hib-vaccinated asthmatic and non-asthmatic pediatric patients. |
IgE, OD |
| 33 |
2018 |
Immune responses to vaccine-preventable diseases among toddlers and preschool children after primary immunization and first booster in Northwestern Algiers, Algeria. |
GMAI |
| 34 |
2018 |
Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial. |
aP, DTaP, HBV, PT, Tdap |
| 35 |
2018 |
In Search of Factors Negatively Affecting Vaccine Immunity to Pertussis in Preschool Children Before the Administration of the First Booster. |
ELISA, GLZ |
| 36 |
2018 |
Incidence and aetiology of bacterial meningitis among children aged 1-59 months in South Asia: systematic review and meta-analysis. |
CI |
| 37 |
2018 |
Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016. |
NTHi, PBP3, STs |
| 38 |
2018 |
Infectious Disease Risk and Vaccination in Northern Syria after 5 Years of Civil War: The MSF Experience. |
KHA, MSF, SIA, VPD |
| 39 |
2018 |
Integrated Safety Profile of a New Approved, Fully-liquid DTaP5-HB-IPV-Hib Vaccine. |
AEs |
| 40 |
2018 |
Long-term regulation of local cytokine production following immunization in mice. |
DTaP, G-CSF, HPV, NET |
| 41 |
2018 |
Nontypable Haemophilus influenzae Septicemia and Urinary Tract Infection Associated with Renal Stone Disease. |
--- |
| 42 |
2018 |
Persistence of Vaccine-Induced Immunity in Preschool Children: Effect of Gestational Age. |
MMR |
| 43 |
2018 |
Public subsidies and the recommendation of child vaccines among primary care physicians: a nationwide cross-sectional study in Japan. |
HPV, PCV |
| 44 |
2018 |
RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein. |
CPS, TT |
| 45 |
2018 |
Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands. |
CMV, IgG, MenC, NHI, SES |
| 46 |
2018 |
Sudden death from acute epiglottitis in a toddler. |
--- |
| 47 |
2018 |
The Incidence of Pediatric Invasive Bacterial Diseases in Nippon Medical School Chiba Hokusoh Hospital before and after the Introduction of Conjugate Vaccines. |
IPD |
| 48 |
2018 |
The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States. |
NDs, OR |
| 49 |
2018 |
The role of vaccines in fighting antimicrobial resistance (AMR). |
AMR, WHO |
| 50 |
2018 |
Utilizing pharmacy intervention in asplenic patients to improve vaccination rates. |
--- |
| 51 |
2018 |
Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016. |
CNMI, DTaP, FSM, HepB, IPV, MMR, PCV, RMI, USAPI, VPDs |
| 52 |
2018 |
Vaccination Practices in Pediatric Dialysis Patients Across Europe. A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group Study. |
CKD, HAV, HBV, MMR, VZV |
| 53 |
2018 |
Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children. |
--- |
| 54 |
2017 |
A review of Haemophilus influenzae disease in Europe from 2000-2014: challenges, successes and the contribution of hexavalent combination vaccines. |
--- |
| 55 |
2017 |
Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines. |
--- |
| 56 |
2017 |
Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran. |
NIP |
| 57 |
2017 |
Collaborative study on saccharide quantification of the Haemophilus influenzae type b component in liquid vaccine presentations. |
BSP, EDQM, HPAEC-PAD, WHO |
| 58 |
2017 |
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants. |
MenC |
| 59 |
2017 |
DTaP5-HB-IPV-Hib Vaccine (Vaxelis): A Review of its Use in Primary and Booster Vaccination. |
--- |
| 60 |
2017 |
Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand. |
ICERs, QALY, THB |
| 61 |
2017 |
Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review. |
WHO |
| 62 |
2017 |
Effect of stepwise perinatal immunization education: A cluster-randomized controlled trial. |
--- |
| 63 |
2017 |
Evaluation of the line probe assay for the rapid detection of bacterial meningitis pathogens in cerebrospinal fluid samples from children. |
CSF, LPA, PCR |
| 64 |
2017 |
Experimental design and metabolic flux analysis tools to optimize industrially relevant Haemophilus influenzae type b growth medium. |
--- |
| 65 |
2017 |
Factors That Negatively Affect the Prognosis of Pediatric Community-Acquired Pneumonia in District Hospital in Tanzania. |
CAP, DBS, PCR, S. p, SA |
| 66 |
2017 |
Functional antibodies to Haemophilus influenzae type B, Neisseria meningitidis, and Streptococcus pneumoniae contained in intravenous immunoglobulin products. |
IVIG, PAD |
| 67 |
2017 |
Haemophilus influenzae Type a Meningitis in Immunocompetent Child, Oman, 2015. |
--- |
| 68 |
2017 |
Haemophilus influenzae type b carriage and burden of its related diseases in Chinese children: Systematic review and meta-analysis. |
ALRI, CNKI |
| 69 |
2017 |
Haemophilus influenzae type b meningitis in a vaccinated and immunocompetent child. |
CSF |
| 70 |
2017 |
Haemophilus influenzae type B meningitis: Is there a re-emergence? 24 years of experience in a children's hospital. |
--- |
| 71 |
2017 |
Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid. |
CHO, FHA, GMC, MBL, mHib, TT |
| 72 |
2017 |
High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination. |
GNI, PCV |
| 73 |
2017 |
Immunization status in childhood cancer survivors: A hidden risk which could be prevented. |
--- |
| 74 |
2017 |
Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib). |
MCC |
| 75 |
2017 |
Invasive Haemophilus influenzae Infection in Patients With Cancer. |
NTHi |
| 76 |
2017 |
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants. |
AEs, SAEs |
| 77 |
2017 |
Measuring the timeliness of childhood vaccinations: Using cohort data and routine health records to evaluate quality of immunisation services. |
DTP, Men C, MMR |
| 78 |
2017 |
Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa. |
iNTS, NTS |
| 79 |
2017 |
Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b. |
--- |
| 80 |
2017 |
Multiplexed instrument-free meningitis diagnosis on a polymer/paper hybrid microfluidic biochip. |
aCSF, LAMP, N. meningitidis, POC, S. pneumoniae |
| 81 |
2017 |
Pediatric bacterial meningitis in Japan, 2013-2015 - 3-5 years after the wide use of Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines. |
PCV |
| 82 |
2017 |
Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan. |
DPT, MSF |
| 83 |
2017 |
Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia. |
ALL, VPDs |
| 84 |
2017 |
Single variant bottleneck in the early dynamics of H. influenzae bacteremia in neonatal rats questions the theory of independent action. |
--- |
| 85 |
2017 |
The Asplenic Patient: Post-Insult Immunocompetence, Infection, and Vaccination. |
--- |
| 86 |
2017 |
The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action. |
AIP, CDC, Hia, NRC, PHAC |
| 87 |
2017 |
The evidence for non-typeable Haemophilus influenzae as a causative agent of childhood pneumonia. |
NTHi |
| 88 |
2017 |
The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial. |
--- |
| 89 |
2017 |
Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016. |
DTaP, HepB, MMR, NIS-Child, PCV, VFC |
| 90 |
2017 |
Vaccines to prevent pneumonia in children - a developing country perspective. |
GVAP |
| 91 |
2017 |
[Acute epiglottitis due to Haemophilus influenzae b: A severe consequence of increased skepticism about vaccination]. |
--- |
| 92 |
2016 |
A 15-year retrospective analysis of prognostic factors in childhood bacterial meningitis. |
CI, CSF, ICU, OR |
| 93 |
2016 |
A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate. |
TT |
| 94 |
2016 |
A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b. |
CV, SBA, TTC |
| 95 |
2016 |
Adult-onset Invasive Haemophilus influenzae Type f Caused by Acute Lower Leg Cellulitis. |
Hif |
| 96 |
2016 |
Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines. |
CRM197, DTPa, MenC, PRP, rSBA, SBA |
| 97 |
2016 |
Applying Central Composite Design and Response Surface Methodology to Optimize Growth and Biomass Production of Haemophilus influenzae Type b. |
CCD, PRP, RSM |
| 98 |
2016 |
Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci. |
SBA |
| 99 |
2016 |
Clinical and Molecular Epidemiology of Childhood Invasive Nontypeable Haemophilus influenzae Disease in England and Wales. |
MLST, NTHi, PHE |
| 100 |
2016 |
Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants. |
BCG, HEU |
A Search Service for Abbreviation / Long Form
